For: | Hu Q, Chen XP, Tang ZJ, Zhu XY, Liu C. Therapeutic effects of Buzhong Yiqi decoction in patients with spleen and stomach qi deficiency after routine surgery and chemotherapy for colorectal cancer. World J Gastrointest Surg 2024; 16(7): 2183-2193 [PMID: 39087096 DOI: 10.4240/wjgs.v16.i7.2183] |
---|---|
URL: | https://www.wjgnet.com/1948-9366/full/v16/i7/2183.htm |
Number | Citing Articles |
1 |
Hongyan Lin, Dongxuan Ai, Xinling Wang, Shuaijun Cui, Xinghong Li, Bangmei Ye, Lingyu Ruan, Jing Xu, Liqun Wang. Exploration of the key active ingredients and mechanisms of Sparganii Rhizoma-Curcumae Rhizoma compatible formulation against human colorectal cancer through network pharmacology and in vitro experiments. Pharmacological Research - Modern Chinese Medicine 2024; 13: 100532 doi: 10.1016/j.prmcm.2024.100532
|
2 |
Qiwen Lu, Jiaxin Jiang, Xi Wang, Rongling Wang, Xuan Han. Advancements in the Research of Astragalus membranaceus for the Treatment of Colorectal Cancer. The American Journal of Chinese Medicine 2025; 53(01): 119 doi: 10.1142/S0192415X25500065
|
3 |
Song Qiao, Xiaolong Li, Shangzhen Yang, Hua Hua, Chengtao Mao, Wanling Lu. Investigating the PI3K/AKT/mTOR axis in Buzhong Yiqi Decoction’s anti-colorectal cancer activity. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-89018-9
|